• Profile
Close

High systemic immune-inflammation index is an adverse prognostic factor for patients with gastroesophageal adenocarcinoma

Annals of Surgery Feb 12, 2021

Jomrich G, Paireder M, Kristo I, et al. - In various malignancies, the systemic immune-inflammation index (SII) based on peripheral neutrophil, lymphocyte, and platelet counts has exhibited a prognostic ability. In patients with resectable adenocarcinoma of the gastroesophageal junction treated with or without neoadjuvant therapy, the clinical role of the systemic immune-inflammation index was examined. Researchers obtained data of consecutive patients undergoing esophagectomy (n = 320) from 1992 to 2016. Analysis revealed the independent value of elevated SII as an adverse prognostic factor in patients with resectable gastroesophageal adenocarcinomas with and without neoadjuvant treatment. High SII was significantly correlated with lower overall and disease-free survival in both neoadjuvantly treated and primarily resected patients.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay